Novel report of expression and function of CD97 in malignant gliomas: correlation with Wilms tumor 1 expression and glioma cell invasiveness

Analysis of CD97 Expression and Manipulation: Antibody Treatment but Not Gene Targeting Curtails Granulocyte Migration

(2014) H. Veninga et al.   JOURNAL OF IMMUNOLOGY

WT1 Peptide Vaccine as a Paradigm for “Cancer Antigen-Derived Peptide”-Based Immunotherapy for Malignancies: Successful Induction of Anti-Cancer Effect by Vaccination with a Single Kind of WT1 Peptide

(2012) Yoshihiro Oka et al.   Anti-Cancer Agents in Medicinal Chemistry

An Extensive Invasive Intracranial Human Glioblastoma Xenograft Model

(2010) Yunge Zhao et al.   AMERICAN JOURNAL OF PATHOLOGY

WT1 peptide vaccine, one of the most promising cancer vaccines: its present status and the future prospects

(2010) Yoshihiro Oka et al.   Immunotherapy

The impact of expressions of CD97 and its ligand CD55 at the invasion front on prognosis of rectal adenocarcinoma

(2010) Shao-Liang Han et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

WT1 (Wilms' Tumor Gene 1): Biology and Cancer Immunotherapy

(2010) H. Sugiyama   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Wilms’ tumor 1 silencing decreases the viability and chemoresistance of glioblastoma cells in vitro: a potential role for IGF-1R de-repression

(2010) Mike Y. Chen et al.   JOURNAL OF NEURO-ONCOLOGY

Wilms' Tumor 1 Gene Expression in Hepatocellular Carcinoma Promotes Cell Dedifferentiation and Resistance to Chemotherapy

(2009) Maria J. Perugorria et al.   CANCER RESEARCH

The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research

(2009) M. A. Cheever et al.   CLINICAL CANCER RESEARCH

WT 1 expression in nevi and melanomas: a marker of melanocytic invasion into the dermis

(2009) M. C. Garrido-Ruiz et al.   JOURNAL OF CUTANEOUS PATHOLOGY

Effect of WT1 gene silencing on the tumorigenicity of human glioblastoma multiforme cells

(2009) Aaron J. Clark et al.   JOURNAL OF NEUROSURGERY

Actin: a novel interaction partner of WT1 influencing its cell dynamic properties

(2009) T Dudnakova et al.   ONCOGENE

Assessing the Impact of Tissue Devitalization Time on Genome-wide Gene Expression Analysis in Ovarian Tumor Samples

(2008) Catherine I. Dumur et al.   DIAGNOSTIC MOLECULAR PATHOLOGY

Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiforme

(2008) Shuichi Izumoto et al.   JOURNAL OF NEUROSURGERY

The Wilms' tumour suppressor WT1 is involved in endothelial cell proliferation and migration: expression in tumour vessels in vivo

(2008) N Wagner et al.   ONCOGENE

Role of the Wilms’ tumour transcription factor, Wt1, in blood vessel formation

(2008) Holger Scholz et al.   PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY

Adhesion-GPCRs: emerging roles for novel receptors

(2008) Simon Yona et al.   TRENDS IN BIOCHEMICAL SCIENCES